Scott M. Kelly comments on issues facing the 5-year-old Patent Trial and Appeal Board in, “Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It,” in Bloomberg Technology.
Click here to read the article.
Posted: September 20, 2017
Scott M. Kelly comments on issues facing the 5-year-old Patent Trial and Appeal Board in, “Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It,” in Bloomberg Technology.
Click here to read the article.
Posted: September 20, 2017
